Richard C Shelton Selected Research

Nausea

1/2020	Real-world approach to managing dysgeusia following the use of esketamine nasal spray: a case report.
1/2019	A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Adjunctive Pimavanserin in Patients With Major Depressive Disorder and an Inadequate Response to Therapy (CLARITY).
1/2019	Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
1/2019	Serotonin and Norepinephrine Reuptake Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard C Shelton Research Topics

Disease

42	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 10/2005
33	Bipolar Disorder (Manic Depressive Psychosis) 02/2022 - 07/2003
14	Treatment-Resistant Depressive Disorder 10/2020 - 10/2005
8	Weight Gain 11/2021 - 01/2006
6	Mania (Manias) 01/2021 - 12/2004
6	Body Weight (Weight, Body) 01/2020 - 01/2009
6	Mood Disorders (Mood Disorder) 01/2017 - 07/2003
6	Depressive Disorder (Melancholia) 07/2013 - 07/2007
5	Sleepiness 12/2020 - 02/2007
4	Nausea 01/2020 - 01/2019
4	Anxiety Disorders (Anxiety Disorder) 10/2019 - 02/2015
4	Fatigue 01/2019 - 01/2007
4	Mental Disorders (Mental Disorder) 03/2017 - 01/2007
3	Dysgeusia (Parageusia) 01/2020 - 01/2019
3	Obesity 01/2017 - 11/2015
3	Pain (Aches) 01/2017 - 07/2013
3	Schizophrenia (Dementia Praecox) 12/2016 - 11/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 01/2006
2	Headache (Headaches) 01/2019 - 01/2018
2	Dizziness (Lightheadedness) 01/2019 - 01/2019
2	Vertigo (Positional Vertigo) 01/2019 - 01/2019
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 01/2010
2	Inflammation (Inflammations) 05/2016 - 08/2014
2	Medically Unexplained Symptoms 01/2016 - 11/2007
2	Substance-Related Disorders (Drug Abuse) 02/2015 - 06/2014
2	Narcolepsy 12/2008 - 02/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2020
1	Vomiting 01/2020
1	Bulimia (Binge Eating) 01/2020
1	Fibromyalgia (Fibrositis) 01/2019
1	Social Phobia 01/2019
1	Diarrhea 01/2019
1	Musculoskeletal Pain 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Panic Disorder (Panic Attack) 01/2019
1	Tachycardia (Tachyarrhythmias) 01/2019
1	Tremor (Tremors) 01/2019
1	Ectopic Pregnancy 01/2018
1	Neurobehavioral Manifestations 01/2018
1	Syncope (Fainting) 01/2018
1	Psychomotor Agitation (Akathisia) 01/2017
1	Dyskinesias (Dyskinesia) 01/2017
1	Insulin Resistance 11/2016

Drug/Important Bio-Agent (IBA)

30	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2007
19	LithiumIBA 02/2022 - 02/2014
16	Quetiapine Fumarate (Seroquel)FDA Link 01/2022 - 02/2014
14	Antipsychotic Agents (Antipsychotics)IBA 02/2022 - 12/2004
10	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2018 - 12/2007
9	Olanzapine (Zyprexa)FDA Link 12/2016 - 07/2003
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2007
6	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2019 - 11/2006
6	5-methyltetrahydrofolateIBA 05/2016 - 01/2009
5	Escitalopram FDA Link 01/2020 - 10/2011
5	ziprasidone (Geodon)FDA Link 01/2018 - 07/2007
5	Fluoxetine (Prozac)FDA LinkGeneric 09/2009 - 07/2003
5	Serotonin (5 Hydroxytryptamine)IBA 12/2007 - 11/2004
4	EsketamineIBA 01/2020 - 01/2018
4	Paroxetine (Paxil)FDA LinkGeneric 01/2016 - 12/2004
4	ProlactinIBA 11/2010 - 01/2009
3	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 08/2011
3	Bupropion (Wellbutrin)FDA LinkGeneric 11/2021 - 03/2004
3	pimavanserinIBA 12/2020 - 01/2019
3	Nasal SpraysIBA 01/2020 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 05/2016 - 08/2010
3	Biomarkers (Surrogate Marker)IBA 02/2015 - 08/2014
3	Risperidone (Risperdal Consta)FDA LinkGeneric 11/2011 - 12/2004
3	olanzapine-fluoxetine combination (Symbyax)FDA Link 05/2010 - 10/2005
2	Triglycerides (Triacylglycerol)IBA 02/2022 - 03/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 02/2022 - 07/2013
2	Sertraline (Zoloft)FDA LinkGeneric 01/2022 - 11/2006
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2019 - 11/2007
2	LeptinIBA 01/2017 - 08/2011
2	Insulin (Novolin)FDA Link 11/2016 - 08/2011
2	BenzodiazepinesIBA 02/2015 - 06/2014
2	Modafinil (Provigil)FDA Link 12/2008 - 02/2007
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 11/2021
1	SDMIBA 10/2020
1	Citalopram FDA LinkGeneric 01/2020
1	AntiemeticsIBA 01/2020
1	vasectrin II (VS II)IBA 10/2019
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 03/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2017
1	Excitatory Amino Acid AntagonistsIBA 08/2016
1	N-Methylaspartate (NMDA)IBA 08/2016
1	Ketamine FDA LinkGeneric 08/2016
1	RNA (Ribonucleic Acid)IBA 05/2016
1	Complementary DNA (cDNA)IBA 05/2016
1	iloperidone FDA Link 02/2016
1	APTIBA 01/2016
1	CalciumIBA 12/2015

Therapy/Procedure

9	Therapeutics 01/2019 - 06/2006
4	Drug Therapy (Chemotherapy) 12/2017 - 04/2007
2	Injections 11/2011 - 11/2010
2	Patient Readmission 11/2011 - 11/2010
1	Polypharmacy 10/2019
1	Secondary Prevention 01/2019
1	Intravenous Administration 08/2016